Lulican Cream contains Luliconazole 1% w/w, a broad-spectrum antifungal agent belonging to the imidazole class. It is indicated for the topical treatment of superficial fungal infections such as dermatophytosis, candidiasis, and pityriasis versicolor. Luliconazole exerts its antifungal effect by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, thereby disrupting membrane integrity and leading to fungal cell death. The cream formulation ensures effective penetration into the stratum corneum, providing sustained antifungal activity. Lulican Cream is typically applied once daily to the affected area and surrounding skin after cleansing and drying, with treatment duration varying based on the type and severity of the infection, generally ranging from one to two weeks. It is well tolerated, with minimal local adverse effects such as mild burning, itching, or erythema reported in some patients. Lulican Cream should be used with caution in individuals with known hypersensitivity to luliconazole or any excipients. It is not intended for use in systemic fungal infections or on mucous membranes. Patients are advised to complete the full course of therapy to prevent recurrence and to avoid occlusive dressings unless directed by a healthcare professional.